Table 3 Transfusion characteristics
Patients | Overall (n = 3502) | Infected (N = 476) | Non-infected (N = 3026) | p value |
|---|---|---|---|---|
RBC [n (%)] | 1235 (35) | 272 (57) | 963 (32) | <0.001 |
RBC > 14 days [n (%)] | 1053 (30) | 224 (47) | 829 (27) | <0.001 |
FFP [n (%)] | 602 (17) | 159 (33) | 443 (15) | <0.001 |
Platelets [n (%)] | 621 (18) | 157 (33) | 464 (15) | <0.001 |
Time between (first) transfusion and infection (days) | ||||
RBC [median (IQR)] | 6 (3–10) | |||
FFP [median (IQR)] | 6.5 (4–10) | |||
Platelets [median (IQR)] | 7 (4–10) | |||
Blood products in transfused patients | Overall (n = 1304) | Infected (n = 288) | Non-infected (N = 1016) | p value |
|---|---|---|---|---|
RBC | ||||
No. of units [median (IQR)] | 4 (2–8) | 5 (2–11) | 4 (2–7) | <0.001 |
No. of units >14 days [median (IQR)] | 3 (1–6) | 4 (1–8) | 2 (1–6) | <0.001 |
FFP | ||||
No. of units [median (IQR)] | 0 (0–0) | 0 (0–3) | 0 (0–0) | <0.001 |
Platelets | ||||
No. of units [median (IQR)] | 0 (0–0) | 0 (0–2) | 0 (0–0) | <0.001 |